In two patients aged 18 (#103) and 44 (#191) with the classic clinical APS-1 triad and a genetically verified diagnosis, antibodies against IL-22 were not detected, as also described earlier [6]. This evidence concerns the gene IL22 and autoimmune polyendocrine syndrome type 1.